RANGRAM CHANDRAN, MD
Ophthalmology Physician · MODESTO, CA
Individual Active NPI 1194714642
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 846 | 11,566 | $3,815,041 | $1,739,873 | $1,355,210 |
| 2023 | 824 | 11,352 | $3,761,443 | $1,770,835 | $1,381,368 |
| 2022 | 796 | 8,460 | $2,112,677 | $1,048,519 | $794,501 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 3,495 | $171 | $136 |
| 92014 | Established patient complete exam of visual system | 1,931 | $138 | $101 |
| 67028 | Injection of drug into eye | 1,428 | $121 | $94 |
| 92250 | Photography of the retina | 1,296 | $37 | $30 |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 1,165 | $182 | $143 |
| 92134 | Imaging of retina | 1,077 | $44 | $34 |
| J7999 | Compounded drug, not otherwise classified | 546 | $93 | $71 |
| J0178 | Injection, aflibercept, 1 mg | 168 | $786 | $627 |
| 92004 | New patient complete exam of visual system | 154 | $163 | $114 |
| J3590 | Unclassified biologics | 67 | $1,688 | $1,345 |
| 67210 | Destruction of growth of retina using a laser | 47 | $533 | $423 |
| 92012 | Established patient problem focused exam of visual system | 42 | $86 | $65 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | A81157 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in California
- NPI 1346239803
- NPI 1891954772
- NPI 1275504524
- NPI 1225181399
- NPI 1114940301
- NPI 1992382022
- NPI 1255351755
- NPI 1275673709
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.